Addresses specific issues of the Canadian Biotechnology Strategy renewal pertaining to the health sector. Raises a number of consultation questions on which views are being sought within the areas of: health protection, health industries, and health sciences. Puts forward three central questions that revolve around application, development and research: how can the potential of biotechnology be best managed for the public health advantage of Canadians?; how can a globally competitive Canadian based industry in health biotechnology be best built and sustained?; and how can health biotechnology research be supported and focussed to most effectively contribute to health protection and industrial development?